Imfinzi 500 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB25FKNAF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,915
Award facts
- Contract value 100% obligated
- $15,915.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,915.42 firm fixed price delivery order to AmerisourceBergen Drug Corp for IMFINZI 500 mg/10 mL vials on August 4, 2025, with an ultimate completion date of August 25, 2025. IMFINZI is a prescription immunotherapy medication used in cancer treatment. The award was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies branded and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to defense and veteran healthcare systems. The DLA Troop Support Medical IDC enables the company to fulfill pharmaceutical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. This specific delivery order represents a routine fulfillment of pharmaceutical products under the broader contract vehicle that demonstrates the vendor's ongoing capability to meet federal medical supply requirements through open competition.
Quick answers
Who was awarded contract SPE2DB25FKNAF?
SPE2DB25FKNAF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FKNAF worth?
The government has obligated $15,915 on SPE2DB25FKNAF.
Is contract SPE2DB25FKNAF an order under another contract?
Yes. SPE2DB25FKNAF is a delivery order under SPE2DB24D2101, an indefinite delivery contract.
Was contract SPE2DB25FKNAF competed?
The extent of competition for SPE2DB25FKNAF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award